Development of gene theropy for glaucoma by neaws of modulation of proteoglycan praduction in aqueous outflow rocite
Development of gene theropy for glaucoma by neaws of modulation of proteoglycan praduction in aqueous outflow rocite
批准号:
08457464
负责人:
TANIHARA Hidenobu
金额:
$4.74万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have investigated our hypothesis on mechanism of primary angly open glaucoma, that an interactive relationship between TGF-beta2 in aqueous humor and proteoglycan (PG) expression in trabecular meshwork (TM) cells, may play crucial roles in regulation of aqueous outflow resistance.Gene expression of the PG core protein was screened in human and bovine cultured TM cells by reverse transcription -initiated polymerase chain reaction (RT-PCR) and the RT-PCR experiments showed that cDNA fragments of the three PGs (decorin, lumican and fibromodulin). Subsequently, the TM cells were cultured with TGF-beta2, and the changes of gene expressions of the PGs were investigated. As a result, the expression of three PGs (decorin, lumican and fibromodulin) were up-regulated by TGF-beta2 stimulation.In addition, we assessed TGF-beta2 in aqueous humor which were collected from variable glaucomatous patients and non-glaucomatous (cataractous) patients with a specific-capture ELISA.Our study revealed that increased levels of TGF-beta2 in aqueous humor was found only in eyes with POAG,but not with EXS and PACG.These findings suggested that increased levels of TGF-beta2 may be different from other types of glaucoma.Furthrmore, we attempted to create a POAG model by means of TGF-beta2 gene transfer and resultant increase of proteolglycan production in TM cells, and in autocrine and/or paracrine manners of production. We have succeeded to efficiently introduce genes to primate and human TM cells by the HVJ liposome method. This results showed the potential of this method for a somatic gene therapy of the trabecular meshwork to treat glaucoma.These result suggested the potential role of increased levels of TGF-beta2 in aqueous humor and resultant increase of proteolglycan production in the pathogenesis of primary open angle glaucoma, and the gene transfer methods may be useful to treat glaucoma.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
K.Okazaki, H.Tanihara, M.Hangai, M.Inatani, M.Honjo, Y.Kaneda, B.Y.J.T.Yue, Y.Honda: "Facilitated introduction of DNA and oligonucleotides into primate trabecular meshwork cells by HVJ liposome methods." Invest Ophthalmil Vis Sci.(in press).
K.Okazaki、H.Tanihara、M.Hangai、M.Inatani、M.Honjo、Y.Kaneda、B.Y.J.T.Yue、Y.Honda:“通过 HVJ 脂质体方法促进将 DNA 和寡核苷酸引入灵长类小梁网细胞。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Muto T他: "Transforiming growth factor β2 up-regulated expression of proteoglycan decorin in trabecular meshwork cells." Invest Cphthalmol Vis.Sci. (印刷中). (1998)
Muto T 等人:“转化生长因子 β2 上调小梁网细胞中蛋白多糖核心蛋白的表达。”Invest Cphamol Vis.Sci(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tanihara,et al.: "Prolonged impairment of peripheral corneal epithelial barrier function afper Successful frabeculectomy" American Journal of Ophthalmology. (印刷中). (1997)
Tanihara 等人:“成功的小梁切除术后周围角膜上皮屏障功能的长期损害”美国眼科杂志(1997 年出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Tanihara, N.Yokoi, A.Komuro, Y.Honda, S.Kinoshita: "Prolonged impairment of peripheral corneal epithelium barrier function after successful trabeculectomy." American Journal of Ophthalmology. 123. 487-493 (1997)
H.Tanihara、N.Yokoi、A.Komuro、Y.Honda、S.Kinoshita:“成功小梁切除术后周边角膜上皮屏障功能长期受损。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hangai M 他: "Introduction of DNA into the rat and primate trabecular meshwork by fusogenic liposomes" Invest Ophthalmol Vis Sci. (印刷中). (1998)
Hangai M 等人:“通过融合脂质体将 DNA 引入大鼠和灵长类动物小梁网”Invest Ophasemol Vis Sci(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 24 条
Study on development of new therapeutic methods based on plasticity of trabecular meshwork cells
-
批准号:17K19729
-
项目类别:Grant-in-Aid for Challenging Research (Exploratory)
-
资助金额:$4.08万
-
财政年份:2017
-
负责人:TANIHARA Hidenobu
-
依托单位:
Investigation of glaucoma pathology focusing on epigenome and fibrocyte in aqueous humor dynamics and wound healing
-
批准号:17H04351
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.9万
-
财政年份:2017
-
负责人:TANIHARA Hidenobu
-
依托单位:
4-dimention live imaging of inflamatory cells in conjunctiva after glaucoma surgery
-
批准号:25670735
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2013
-
负责人:TANIHARA Hidenobu
-
依托单位:
Establishment of therapeutic assessment in glaucoma neuroprotection using live-imaging of axonal transport in optic nerve
-
批准号:23659814
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:TANIHARA Hidenobu
-
依托单位:
The effects of aqueous bioactive molecules on aqueous outflow dynamics and filtration-surgery results
-
批准号:23390403
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.98万
-
财政年份:2011
-
负责人:TANIHARA Hidenobu
-
依托单位:
New therapeutic approach for glaucoma via drug-mediated bleb regulation
-
批准号:20390449
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.31万
-
财政年份:2008
-
负责人:TANIHARA Hidenobu
-
依托单位:
The investigation for molecular mechanisms of aqueous humor outflow and the creation of new treatments for intraocular pressure elevation in glaucomatous eyes
-
批准号:18390470
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.59万
-
财政年份:2006
-
负责人:TANIHARA Hidenobu
-
依托单位:
The development and clinical application of molecular-based new medical treatments for glaucoma
-
批准号:16390500
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.22万
-
财政年份:2004
-
负责人:TANIHARA Hidenobu
-
依托单位:
A research about the new therapy for glaucomatous optic nerve damage based on the endogenous neuroprotective system
-
批准号:14370561
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.54万
-
财政年份:2002
-
负责人:TANIHARA Hidenobu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Decorin调控ADAMTS12 m6A甲基化与IL12B/VEGF免疫互作介导肥胖合并妊娠期糖尿病子代心血管疾病的作用研究
-
批准号:2026JJ81694
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:罗慧
-
依托单位:
探讨青光眼小梁滤过泡原位重建术及其诱导Decorin/TGF-β影响青光眼滤过通道瘢痕再形成的机制
-
批准号:2024JJ7015
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
香烟烟雾通过Decorin-PAI-1-p53/p16调控肺泡成纤维细胞衰老在肺气肿的作用及干预研究
-
批准号:82300047
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:胡蔚萍
-
依托单位:
Decorin通过负调控c-Met介导的PI3K/AKT/mTOR自噬通路影响瘢痕疙瘩发生发展的机制研究
-
批准号:82303987
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:金玟言
-
依托单位:
Decorin-siRNA转染半腱肌腱促进前交叉韧带重建后移植物韧带化及其机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:
-
依托单位:
基于生物力学调控Decorin介导脂肪酸氧化代谢改善血管内皮损伤及动脉粥样硬化的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:徐诗岳
-
依托单位:
circSTX6 编码的新蛋白 circSTX6-144aa 结合 Decorin促进鼻咽癌侵袭转移和增殖
-
批准号:2022JJ40659
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:邓湘赢
-
依托单位:
Decorin-Th17通路在支气管扩张症合并侵袭性肺曲霉病中的作用机制研究
-
批准号:82170051
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2021
-
负责人:梁硕
-
依托单位:
Decorin修饰的脐带间充质干细胞治疗肺纤维化的作用与机制
-
批准号:2020A151501079
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2020
-
负责人:左万里
-
依托单位:
microRNA-17-92cluster通过mTORC1/decorin通路调控毛囊干细胞微环境及生长期启动的作用研究
-
批准号:81972955
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:景璟
-
依托单位: